Biogen, Inc. (BIIB)
216.65
-1.85
(-0.85%)
USD |
NASDAQ |
Aug 31, 16:00
216.78
+0.13
(+0.06%)
After-Hours: 20:00
Biogen Net Income (TTM) : 834.60M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 834.60M |
| March 31, 2026 | 1.372B |
| December 31, 2025 | 1.293B |
| September 30, 2025 | 1.609B |
| June 30, 2025 | 1.531B |
| March 31, 2025 | 1.479B |
| December 31, 2024 | 1.632B |
| September 30, 2024 | 1.614B |
| June 30, 2024 | 1.158B |
| March 31, 2024 | 1.167B |
| December 31, 2023 | 1.162B |
| September 30, 2023 | 1.462B |
| June 30, 2023 | 2.665B |
| March 31, 2023 | 3.131B |
| December 31, 2022 | 2.962B |
| September 30, 2022 | 2.392B |
| June 30, 2022 | 1.575B |
| March 31, 2022 | 1.542B |
| December 31, 2021 | 1.728B |
| September 30, 2021 | 2.106B |
| June 30, 2021 | 2.492B |
| March 31, 2021 | 3.073B |
| December 31, 2020 | 4.061B |
| September 30, 2020 | 5.143B |
| June 30, 2020 | 5.985B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.872B |
| December 31, 2019 | 5.888B |
| September 30, 2019 | 5.394B |
| June 30, 2019 | 5.291B |
| March 31, 2019 | 4.712B |
| December 31, 2018 | 4.474B |
| September 30, 2018 | 3.363B |
| June 30, 2018 | 3.146B |
| March 31, 2018 | 3.094B |
| December 31, 2017 | 2.670B |
| September 30, 2017 | 3.484B |
| June 30, 2017 | 3.288B |
| March 31, 2017 | 3.474B |
| December 31, 2016 | 3.696B |
| September 30, 2016 | 3.876B |
| June 30, 2016 | 3.866B |
| March 31, 2016 | 3.742B |
| December 31, 2015 | 3.593B |
| September 30, 2015 | 3.647B |
| June 30, 2015 | 3.484B |
| March 31, 2015 | 3.282B |
| December 31, 2014 | 2.942B |
| September 30, 2014 | 2.516B |
| June 30, 2014 | 2.148B |
| March 31, 2014 | 1.915B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | -564.78M |
| AbbVie, Inc. | 6.274B |
| Regeneron Pharmaceuticals, Inc. | 4.329B |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Amgen, Inc. | 8.743B |